| Ytd | 2.68% | |
| 1y | 106.79% |
| Open | 81.05 | Prev Close | 80.79 | Low | 79.18 | High | 81.17 | Mkt Cap | 784.44M |
| Vol | 103.69K | Avg Vol | 316.02K | EPS | -2.44 | P/E | -32.85 | Forward P/E | N/A |
| Beta | -5.27 | Short Ratio | 0.70 | Inst. Own | 44.28% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 71.12 | 200-d Avg | 76.06 | 1yr Est | 4.87 |
DRUG News
The mean of analysts' price targets for Bright Minds Biosciences Inc. (DRUG) points to a 97.4% upsid
SOUTH SAN FRANCISCO, Calif., July 31, 2026 (GLOBE NEWSWIRE) -- Vistagen (Nasdaq: VTGN), a late clini
The consensus price target hints at a 107.5% upside potential for Bright Minds Biosciences Inc. (DRU
Bright Minds Biosciences Inc. (DRUG) might move higher on growing optimism about its earnings prospe
NEW YORK, May 26, 2026 (GLOBE NEWSWIRE) -- Bright Minds Biosciences, Inc. (“Bright Minds,” “BMB” or
Bright Minds Biosciences develops serotonin-based therapeutics for neurological and neuropsychiatric
https://www.hhs.gov/press-room/fda-accelerates-action-treatments-serious-mental-illness-following-ex
https://www.cbsnews.com/news/psychedelic-drug-ibogaine-ptsd-trump-to-sign-executive-order/
Bright Minds Biosciences Inc. (NASDAQ: DRUG - Get Free Report) has been given a consensus recommenda
https://www.marijuanamoment.net/bipartisan-senators-file-bill-to-support-psychedelics-research-and-t
NEW YORK, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Bright Minds Biosciences, Inc. (“Bright Minds,” “BMB” or
Bright Minds Biosciences Inc. (NASDAQ: DRUG - Get Free Report) has been assigned an average rating o
NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG)
NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG)
Bright Minds Biosciences remains a "Strong Buy" after positive phase 2 data for BMB-101 in drug-resi
NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG)
Bright Minds Biosciences Inc. (NASDAQ: DRUG) stock is trading higher on Tuesday after the company sh
NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (CSE: DRUG) (Nasdaq: DRUG)
Shares of Bright Minds Biosciences Inc (NASDAQ: DRUG, CSE:DRUG) jumped almost 25% after the company
– Conference Call and Live Webcast at 8AM ET – NEW YORK, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Bright Mi
Bright Minds Biosciences Inc. (NASDAQ: DRUG - Get Free Report)'s share price rose 4.2% during tradin
Shares of Bright Minds Biosciences Inc. (NASDAQ: DRUG - Get Free Report) have received an average ra
For three decades, central nervous system (CNS) drug development was a tough space for investors, sc
Tuesday saw 132 companies set new 52-week lows.
On Thursday, 369 companies hit new 52-week lows.
Friday's session saw 225 companies set new 52-week lows.
On Thursday, 283 companies set new 52-week lows.
On Tuesday, 91 stocks hit new 52-week lows.
On Monday, 198 companies hit new 52-week lows.
On Friday, 135 companies reached new 52-week lows.
Gainers Panbela Therapeutics, Inc. (NASDAQ: PBLA) shares jumped 53% to close at $0.58 on Friday.
Gainers Venus Concept Inc. (NASDAQ: VERO) jumped 54.9% to settle at $0.5419 on Friday. The compan
Gainers Mobile Global Esports Inc. (NASDAQ: MGAM) shares surged 103.9% to settle at $5.30 on Tues
Gainers
Gainers GigaCloud Technology Inc (NASDAQ: GCT) shares jumped 145% to $38.45 on continued volatil
Gainers
Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares climbed 135.9% to close at $2.17 on T
Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares jumped 297% to $3.66.
During Thursday, 351 stocks hit new 52-week lows.
During Wednesday's trading, 435 companies set new 52-week lows.
Tuesday's session saw 729 companies set new 52-week lows.
On Monday, 524 stocks hit new 52-week lows.
On Friday, 368 stocks hit new 52-week lows.